Kejako Company

Kejako develops a non-invasive solution for interested presbyopic patients seeking to keep their quality of life through the compensation of visual accommodation decay. Addressing presbyopia in the field of ophthalmology, with an anti-aging mindset in order to treat the gradual loss of visual accommodation.
Technology: P4 Medicine
Industry: P4 Medicine
Headquarters: Geneva
Founded Date: 2015-07-01
Employees Number: 1-10
Funding Status: Seed
Investors Number: 2
Total Funding: CHF700K
Estimated Revenue: $1M to $10M
Last Funding Type: Seed

Visit Website
Register and Claim Ownership